Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$1.28 - $1.6 $4,664 - $5,830
3,644 Added 26.75%
17,265 $24,000
Q3 2023

Nov 13, 2023

BUY
$1.36 - $1.77 $18,524 - $24,109
13,621 New
13,621 $19,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $49,286 - $83,694
-30,998 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$2.02 - $3.92 $62,615 - $121,512
30,998 New
30,998 $76,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.41 $75,794 - $130,416
-12,528 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$6.66 - $10.92 $83,436 - $136,805
12,528 New
12,528 $124,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $360M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.